Page 62 - Clinical Development News Today

Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The "XELJANZ Market Drug Insight and Market Forecast - 2032" drug pipelines has been added to ResearchAndMarkets.com's offering. "XELJANZ Market Drug Insight and Market Forecast - 2032" report provides comprehensive insights about XELJANZ for Ulcerative Colitis (UC) in the seven major markets. A detailed picture of the XELJANZ for ulcerative colitis in the 7MM, i.e., the United States, EU4 (Germany, France, Italy and Spain) and t...

Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The

Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The

/PRNewswire/ -- The "Crovalimab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.coms offering. This report...

Healthcare breakthroughs have long-standing barriers when it comes to unlocking the powerful insights trapped in medical imaging data.

/PRNewswire/ -- The "Cendakimab Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.coms offering. This report...

ROCKVILLE, Md.and SUZHOU,China, Nov. 21, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical c...

Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The

Dublin, Nov. 22, 2023 (GLOBE NEWSWIRE) -- The

A cornerstone paper published in peer-reviewed scientific journal, Cancer Cell, has demonstrated a new way to treat specific blood cancers.